CARAMEL - Digital platform for self-monitoring and self-care

Context:

Women's cardiovascular health is an urgent unmet clinical need, as reported by the European Society of Cardiology (ESC). CVD is the leading cause of death in women in the European Union, with 17 % of women dying from CVD before the age of 65 years (European Society of Cardiology-ESC, 2020), also presenting with many non-fatal CVD events at a young age with sequelae throughout life. CVD is underdiagnosed, undertreated and poorly understood, with prevention being especially important in the period around menopause, where women's cardiovascular risk increases

Aim of the project:

It is in this context that the CARAMEL project was born, which under the coordination of Vicomtech, offers an innovative model of personalized prevention aimed at women aged 40 to 60 years. The project is based on a stratification model that considers additional female-specific risk factors within the CVD risk models. In addition, it aims to better personalize cardiovascular risk assessment using information available from medical records, diagnostic images, etc. as well as new technologies based on molecular or imaging markers.

Role of Vicomtech:

Vicomtech, coordinator of the project and with a solid track record in European projects under the Horizon 2020 and Horizon Europe programs, leads the development and management of CARAMEL and applies its expertise in artificial intelligence to develop specialized AI models, as well as defining the digital platform on which to build the developments, providing a solid technical basis to meet the project's objectives. Vicomtech is also actively involved in the studies where Biogipuzkoa participates together with other clinical institutions in Spain, Croatia, Lithuania and Greece, the results of which will enable the evolution of AI-based cardiovascular risk models at EU level.

Partners:

CARAMEL, which has 25 partners from 11 countries, aims to revolutionize cardiovascular disease (CVD) prevention in women aged 40-60 through an innovative AI-based model for personalized risk assessment and preventive healthcare.